This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Macular Photocoagulation Study Group

Arch Ophthalmol. 1996;114(6):677-688.

Abstract
Objectives
To document the incidence of choroidal neovascularization (CNV) in unaffected fellow eyes among individuals with ocular histoplasmosis and extrafoveal or juxtafoveal CNV in 1 eye; to determine whether the location and type of "histo spots" in the macula predict the site of future CNV development in second eyes; to describe changes over time in neovascular lesions present in fellow eyes at baseline; and to describe changes in visual acuity of fellow eyes with and without CNV at baseline.

Design, Patients, and Setting
Five-year prospective follow-up study of fellow eyes of 516 patients enrolled in 2 randomized clinical trials of laser photocoagulation of extrafoveal and juxtafoveal CNV. Best-corrected visual acuity and reading vision were measured, and both maculas were photographed at baseline and at 6-month intervals.

Main Outcome Measures
Cumulative incidence of CNV in fellow eyes free of neovascular maculopathy at the time of study enrollment, 5-year change in visual acuity of fellow eyes from baseline, and incidence of legal blindness (visual acuity 20/200 in the better eye).

Results
Photographically documented CNV developed in 35 (9%) of 394 eyes initially free of neovascular maculopathy; nevertheless, good visual acuity was maintained in most newly affected eyes until the end of the 5-year follow-up period. Histo spots of any type in the macula at baseline tripled the risk for later development of CNV in comparison to eyes without histo spots in the macula. Although the type of histo spots present in the central macula at baseline did not predict future CNV development, in 32 of 35 second eyes in which CNV developed and in 7 of 9 fellow eyes in which a second area of CNV developed during follow-up, CNV was preceded by an "atypical" histo spot in the same location. Among 122 patients who had bilateral neovascular maculopathy initially, 100 were examined 5 years later; 8 (8%) were legally blind, compared with 3 (1%) of 339 patients examined who had unilateral CNV initially. At the 5-year examination, 355 (81%) of 439 patients examined had a visual acuity of 20/20 or better in at least 1 eye, including 74 (55%) of 134 patients who had bilateral neovascular maculopathy.

Conclusions
Although the incidence of CNV in fellow eyes that initially were unaffected remained low throughout 5 years of follow-up, it persisted at a nearly constant rate. The risk of legal blindness was low, even for patients who had bilateral involvement. Perhaps most important, 81% of all patients followed up for 5 years retained a visual acuity of 20/20 in at least 1 eye, and 20% retained this visual acuity in both eyes. Retrospective review of photographs suggests that the ophthalmologist should pay special attention to areas of the central macula in which new "atypical" histo spots are observed, with the goal of treating CNV that may develop in the same area at a time when the benefits of laser treatment may be greatest.

Author Affiliations
Prepared for the Macular Photocoagulation Study (MPS) Group by C. P. Wilkinson, MD; Barbara S. Hawkins, PhD; Noreen B. Javornik, MS; M. Marvin Newhouse; Jean A. Keller, MS; Neil M. Bressler, MD; Susan B. Bressler, MD; Dean B. Burgess, MD; Stuart L. Fine, MD; Cheryl J. Hiner; Maureen G. Maguire, PhD; and David H. Orth, MD. A list of the members of the MPS Group appears at the end of the article. No member of the MPS Group has any proprietary interest in any commercially available product used in MPS clinical trials.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Hybrid Cohort Individual Sampling Natural History Model of Age-Related Macular Degeneration: Assessing the Cost-Effectiveness of Screening Using Probabilistic Calibration
Karnon et al.
Med Decis Making 2009;29:304-316.
ABSTRACT  

Surgical Removal vs Observation for Idiopathic or Ocular Histoplasmosis Syndrome-Associated Subfoveal Choroidal Neovascularization: Vision Preference Value Scale Findings From the Randomized SST Group H Trial: SST Report No. 17
Submacular Surgery Trials Research Group
Arch Ophthalmol 2008;126:1626-1632.
ABSTRACT | FULL TEXT  

Photodynamic therapy with verteporfin in paediatric and young adult patients: long-term treatment results of choroidal neovascularisations
Lipski et al.
Br J Ophthalmol 2008;92:655-660.
ABSTRACT | FULL TEXT  

Health- and Vision-Related Quality of Life Among Patients With Ocular Histoplasmosis or Idiopathic Choroidal Neovascularization at Enrollment in a Randomized Trial of Submacular Surgery: Submacular Surgery Trials Report No. 5
Submacular Surgery Trials Research Group
Arch Ophthalmol 2005;123:78-88.
ABSTRACT | FULL TEXT  

Surgical Removal vs Observation for Subfoveal Choroidal Neovascularization, Either Associated With the Ocular Histoplasmosis Syndrome or Idiopathic: I. Ophthalmic Findings From a Randomized Clinical Trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9
Submacular Surgery Trials Research Group
Arch Ophthalmol 2004;122:1597-1611.
ABSTRACT | FULL TEXT  

Subconjunctival Doxifluridine Administration Suppresses Rat Choroidal Neovascularization through Activated Thymidine Phosphorylase
Yanagi et al.
IOVS 2003;44:751-754.
ABSTRACT | FULL TEXT  

Age as an Independent Risk Factor for Severity of Experimental Choroidal Neovascularization
Espinosa-Heidmann et al.
IOVS 2002;43:1567-1573.
ABSTRACT | FULL TEXT  

A Preliminary Study of Photodynamic Therapy Using Verteporfin for Choroidal Neovascularization in Pathologic Myopia, Ocular Histoplasmosis Syndrome, Angioid Streaks, and Idiopathic Causes
Sickenberg et al.
Arch Ophthalmol 2000;118:327-336.
ABSTRACT | FULL TEXT  

Reactivation of Inflammatory Lesions in Ocular Histoplasmosis
Callanan et al.
Arch Ophthalmol 1998;116:470-474.
ABSTRACT | FULL TEXT  

Presumed ocular histoplasmosis in the Netherlands---an area without histoplasmosis
Suttorp-Schulten et al.
Br J Ophthalmol 1997;81:7-11.
ABSTRACT | FULL TEXT